Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - BIOCANCELL THERAPEUTICS INC. | exhibit311.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOCANCELL THERAPEUTICS INC. | exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - BIOCANCELL THERAPEUTICS INC. | exhibit312.htm |
| 10-Q - 10-Q FILING - Q2 2011 - BIOCANCELL THERAPEUTICS INC. | filing10q.htm |
EXHIBIT 32. 2
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
I am the Chief Financial Officer of BioCancell Therapeutics Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended June 30, 2011 and filed with the Securities and Exchange Commission (“Form 10-Q”).
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: August 11, 2011
|
||
|
/s/ Jonathan Burgin
|
||
|
Jonathan Burgin
|
||
|
Chief Financial Officer
|
||
|
(Principal Financial Officer)
|